Susan Moran - Sep 14, 2023 Form 3 Insider Report for RayzeBio, Inc. (RYZB)

Role
Chief Medical Officer
Signature
/s/ Jeff Woodley, Attorney-in-fact
Stock symbol
RYZB
Transactions as of
Sep 14, 2023
Transactions value $
$0
Form type
3
Date filed
9/14/2023, 07:37 PM
Previous filing
Jun 15, 2023
Next filing
Nov 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RYZB Common Stock 292K Sep 14, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RYZB Employee Stock Option (Right to Buy) Sep 14, 2023 Common Stock 91.6K $3.24 Direct F1
holding RYZB Employee Stock Option (Right to Buy) Sep 14, 2023 Common Stock 77.8K $3.24 Direct F2
holding RYZB Employee Stock Option (Right to Buy) Sep 14, 2023 Common Stock 195K $3.24 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is subject to an early exercise provision and is immediately exercisable. 25% of the shares vested on September 29, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.
F2 The option is subject to an early exercise provision and is immediately exercisable. 25% of the shares vested on December 3, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.
F3 The option is subject to an early exercise provision and is immediately exercisable. Vesting is monthly over a 48-month period starting January 1, 2023 in equal monthly amounts.

Remarks:

Exhibit 24 - Power of Attorney